New research suggests GLP-1 drugs like Ozempic can help prevent up to 10 different obesity-related cancers in people with type 2 diabetes.
New research has found a potential link between semaglutide use and a rare eye condition called NAION, though more work is needed to prove causation.
Dozens of obesity and diabetes treatments are in the pipeline, some of which may help people lose even more weight than existing drugs like semaglutide.
Experts with the U.S. Preventive Services Task Force say not enough data has been collected to know whether newer obesity medications for teens are safe.
Critics claim that drugs like semaglutide and other GLP-1s can dangerously sap away our muscle mass, but what does the current science actually tell us?
The results of the longest-running trial of semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, are here and looking positive.
More than a third of former semaglutide regained their shed pounds, however.
Semaglutide and other new drugs are the real deal in obesity treatment, but there are many lingering questions about their future.
People who stopped taking Zepbound (tirzepatide) regained much of their lost weight within a year, while those on it kept losing more.
In clinical trials, Eli Lilly's tirzepatide was found to help people lose upwards of 20% of their weight in conjunction with diet and exercise.
People who already lost weight at first went on to shed substantially more pounds than those on a placebo, Eli Lilly's newest clinical trial found.
According to Novo Nordisk, people on Wegovy were 20% less likely to develop serious cardiovascular problems for up to five years when compared to placebo.
The American Academy of Pediatrics' guidelines are the first to emphasize proactive measures for treating childhood obesity, which has risen in recent years.
Over a 10-year period, patients who underwent bariatric surgery were far less likely to develop any cancer and more likely to survive it if they did.
The layoffs are a sign of struggle for an app that surged during the pandemic but has caught flak for dubious fitness goals.
In a new study, people who slept over an hour more than usual ate fewer calories per day.
Left gastric artery embolisation is supposed to work by reducing the production of the so-called hunger hormone, ghrelin.
Of the few decent studies that found some benefit from supplements, there were only small improvements.
Overweight and obese people will soon have a new medical option to help them manage their weight. On Monday, the Boston biotech company Gelesis announced they had received clearance from the Food and Drug Administration to market their novel weight loss aid to the public, a pill-based medical device called Plenity that makes people feel…
In the first case of its kind, the Federal Trade Commission took action against a diet pill seller for both making false claims and paying to juice their standing on Amazon with fake positive reviews. The fruit of garcinia cambogia has been hailed by some as a powerful weight loss supplement. Of course, there’s no…
